• Medable Launches Certification Program For Decentralized Clinical Trials

    Clinical Research News | At the DIA Global Annual Meeting yesterday, Medable presented on its recently established digital certification program for decentralized clinical trials (DCTs) intended to provide life science companies with the design tools and knowledge to scale their study strategies with more of the DCTs “building blocks”—ranging from televisits and eConsent to medication distribution and home nursing and labs.

    Jul 1, 2021

  • Tackling The Environmental Challenge Of E-Waste From Digital Health Devices

    Clinical Research News | Pharmaceutical leaders are being invited to join an emerging dialogue around ways to reduce the growing stream of electronic waste (e-waste) from digital health devices. The conversation has already been launched by some big-name players—Johnson & Johnson (J&J), Philips Electronics, the Waste Electrical and Electronic Equipment (WEEE) Forum, the United Nations Environment Programme, and the Copenhagen Business School among them—who agree on the need to holistically address the problem

    Jun 30, 2021

  • New Accenture Leadership for Medable, Consolidation Around Decentralized Trials, New Products

    Clinical Research News | Partnerships and acquisitions in decentralized clinical trials, risk stratification, AI in clinical research, digital health, and more. Plus new products from Smart Meter, Medidata, Cmed, and Pharmasol.

    Jun 29, 2021

  • In NASH and NASH Cirrhosis, the Focus Should Be on Clinically Meaningful Endpoints

    Clinical Research News | Along with the worldwide rise of obesity comes a rise in people diagnosed with nonalcoholic Steatohepatitis (NASH), where fat stored in the liver causes inflammation, tissue damage, and eventually cirrhosis. NASH represents a major opportunity to find new treatments, as none has been approved specifically for this disease, but clinical trials for NASH treatments should focus on clinically meaningful endpoints.

    Jun 28, 2021